Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CHRONIC HEPATITIS
Autore:
OEHLER G;
Indirizzi:
REHAKLIN FOHRENKAMP BFA,BIRKENWEG 24 D-23879 MOLLN GERMANY
Titolo Testata:
Die medizinische Welt
fascicolo: 3-4, volume: 48, anno: 1997,
pagine: 102 - 109
SICI:
0025-8512(1997)48:3-4<102:CH>2.0.ZU;2-E
Fonte:
ISI
Lingua:
GER
Soggetto:
PRIMARY BILIARY-CIRRHOSIS; CHRONIC ACTIVE HEPATITIS; URSODEOXYCHOLIC ACID; INTERFERON-ALPHA; CLASSIFICATION; DIAGNOSIS; DISEASE; TRIAL;
Keywords:
CHRONIC HEPATITIS; INTERFERON ALPHA THERAPY; AUTOIMMUNE HEPATITIS AND CHOLANGITIS; URSODEOXYCHOLIC ACID THERAPY;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
21
Recensione:
Indirizzi per estratti:
Citazione:
G. Oehler, "CHRONIC HEPATITIS", Die medizinische Welt, 48(3-4), 1997, pp. 102-109

Abstract

Chronic hepatitis is defined as an inflammatory process of the liver that persists for longer than 6 months without showing a tendency to improve. Despite a variety of aetiologies (infectious, autoimmune, toxic, genetic) the morphological picture can be uniform. There is a general tendency for chronic hepatitis to progress to hepatic cirrhosis andpossibly even liver cancer. Of all forms of viral hepatitis, hepatitis B (approx. 10%) and hepatitis C (approx. 80%) are most likely to develop into chronic hepatitis. The only form of therapy to date which isknown to eliminate the virus is treatment with interferon alpha. Autoimmune hepatitis dan be classified into three types on the basis of immunophenomena. Treatment is based primarily on glucocorticoids and azathioprine. Autoimmune mechanisms in the bile ducts may also lead to chronic inflammatory reactions. Treatment with ursodeoxycholic acid can arrest the progression of both primary biliary cirrhosis and primary sclerosing cholangitis, at least in the early stages.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/12/20 alle ore 13:42:00